Nationwide analysis of risk factors for in‐hospital mortality in patients undergoing abdominal aortic aneurysm repair. BJS 2018; 105: 379-387.
Published: 8th February 2018
Authors: M. Trenner, A. Kuehnl, B. Reutersberg, M. Salvermoser, H.‐H. Eckstein
There is increasing awareness that women may have worse outcomes following repair of abdominal aortic aneurysm (AAA). The aim of this study was to analyse the association between sex, age and in‐hospital mortality after AAA using hospital episode data collected routinely at the nationwide level.
Data were extracted from the nationwide statutory Diagnosis Related Group statistics provided by the German Federal Statistical Office. Patients with a diagnosis of intact (non‐ruptured) AAA (ICD‐10 GM I71.4) and procedure codes (OPS; 2005–2013) for endovascular aneurysm repair (EVAR) (5‐38a.1*) or open aneurysm repair (5‐384.5, 5‐384.7), treated from 2005 to 2013, were included. A multilevel multivariable regression model was applied to adjust for medical risk (using the Elixhauser co‐morbidity score), type of procedure, type of admission, and to account for clustering of patients within centres. The primary outcome was in‐hospital mortality.
Some 84 631 patients were identified, of whom 10 039 (11·9 per cent) were women. Women were significantly older than men at admission (median 74 (i.q.r. 69–80)
In Germany, women were older when undergoing AAA repair and were less likely to receive EVAR. Mortality rates were higher in older patients and in women, irrespective of the surgical technique used.Full text
You may also be interested in
Authors: K. Heikkila, I. M. Loftus, D. C. Mitchell, A. S. Johal, S. Waton, D. A. Cromwell et al.
Notes: lower than previously estimated
Cost‐effectiveness of population‐based vascular disease screening and intervention in men from the Viborg Vascular (VIVA) trial.
Authors: R. Søgaard, J. S. Lindholt
Notes: Highly cost effective
Five‐year follow‐up of a randomized clinical trial comparing open surgery, foam sclerotherapy and endovenous laser ablation for great saphenous varicose veins. BJS 2018; 105: 686-691.
Authors: S. Vähäaho, K. Halmesmäki, A. Albäck, E. Saarinen, M. Venermo
Notes: More foam recurrences
Eight‐year follow‐up of a randomized clinical trial comparing ultrasound‐guided foam sclerotherapy with surgical stripping of the great saphenous vein. BJS 2018; 105: 692-698.
Authors: Y. L. Lam, J. A. Lawson, I. M. Toonder, N. H. Shadid, A. Sommer, M. Veenstra et al.
Notes: Surgery better
Authors: M. J. Sweeting, P. Ulug, J. Roy, R. Hultgren, R. Indrakusuma, R. Balm et al.
Notes: Not much help
Follow‐up after endovascular aortic aneurysm repair can be stratified based on first postoperative imaging. BJS 2018; 105: 709-718.
Authors: H. Baderkhan, O. Haller, A. Wanhainen, M. Björck, K. Mani
Notes: Short sealing zones spell trouble
Risk of major amputation in patients with intermittent claudication undergoing early revascularization. BJS 2018; 105: 699-708.
Authors: J. Golledge, J. V. Moxon, S. Rowbotham, J. Pinchbeck, L. Yip, R. Velu et al.
Notes: Early revascularization associated with amputation
Authors: R. E. Clough, R. Spear, K. Van Calster, A. Hertault, R. Azzaoui, J. Sobocinski et al.
Notes: Encouraging results in expert hands
Authors: N. Rudarakanchana, M. P. Jenkins
Notes: Formidable challenge
Cellular and molecular imaging of the arteries in the age of precision medicine. BJS 2018; 105: 311-312.
Authors: R. O. Forsythe, D. E. Newby
Comparative analysis of the outcomes of elective abdominal aortic aneurysm repair in England and Sweden. BJS 2018; 105: 520-528.
Authors: A. Karthikesalingam, M. J. Grima, P. J. Holt, A. Vidal‐Diez, M. M. Thompson, A. Wanhainen et al.
Notes: Improving in England
Participation in bowel screening among men attending abdominal aortic aneurysm screening. BJS 2018; 105: 529-534.
Authors: A. J. Quyn, C. G. Fraser, J. Rodger, A. Digan, A. S. Anderson, R. J. C. Steele et al.
Notes: Maximizing screening benefits